FDA Expands Data Mining Contract With Premier
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is renewing an existing contract for inpatient drug data and awarding a second contract for pediatric inpatient data. Premier’s Perspective database includes drug utilization and outcomes data from over 500 hospitals.
You may also be interested in...
Limitations Of FDA's Adverse Event Reporting System Highlighted By Vioxx
Merck's withdrawal of Vioxx illustrates the shortcomings of adverse event reporting systems for detecting common events
FDA/Kaiser Study Questions Merck's Vioxx Cardiovascular Safety
Vioxx at doses greater than 25 mg/day is associated with increased risk of acute myocardial infarction and sudden cardiac death, study says. Pfizer's Celebrex had a lower risk of cardiovascular events, the study finds.
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability